

浏览全部资源
扫码关注微信
1.中国中医科学院中医临床基础医学研究所,北京市东城区东直门内南小街16号,100700
2.中国中医科学院国际合作处
Received:13 December 2023,
Revised:2024-02-29,
Published:17 June 2024
移动端阅览
张悦,董毅智,李皓月等.香术防感方吸嗅与滴鼻给药方式预防甲型流感H1N1模型小鼠的药效学比较研究[J].中医杂志,2024,65(12):1279-1286.
ZHANG Yue,DONG Yizhi,LI Haoyue,et al.Comparative Study on the Pharmacodynamics of Xiangzhu Fanggan Formula (香术防感方) by Sniffing and Nasal Drops for Prevention of Influenza A H1N1 Virus Infection in Mice[J].Journal of Traditional Chinese Medicine,2024,65(12):1279-1286.
张悦,董毅智,李皓月等.香术防感方吸嗅与滴鼻给药方式预防甲型流感H1N1模型小鼠的药效学比较研究[J].中医杂志,2024,65(12):1279-1286. DOI: 10.13288/j.11-2166/r.2024.12.014.
ZHANG Yue,DONG Yizhi,LI Haoyue,et al.Comparative Study on the Pharmacodynamics of Xiangzhu Fanggan Formula (香术防感方) by Sniffing and Nasal Drops for Prevention of Influenza A H1N1 Virus Infection in Mice[J].Journal of Traditional Chinese Medicine,2024,65(12):1279-1286. DOI: 10.13288/j.11-2166/r.2024.12.014.
目的
2
比较香术防感方吸嗅和滴鼻两种经鼻给药方式预防甲型流感H1N1的有效性及可能作用机制。
方法
2
将56只BALB/c小鼠随机分为正常组、模型组、扎那米韦组、香囊高浓度组、香囊低浓度组、滴鼻高浓度组、滴鼻低浓度组,每组8只。香
囊低、高浓度组分别给予15、30 g香术防感方香囊吸嗅,每天持续24 h;滴鼻低、高浓度组分别给予浓度为0.11、0.22 g/ml香术防感方滴鼻液滴鼻,每次20 μl,每日2次;扎那米韦组给予浓度为1.025 mg/ml扎那米韦溶液滴鼻,每次20 μl,每日2次;正常组、模型组滴鼻20 μl生理盐水,每日2次。各组预防性干预5天。第5天给药1 h后,除正常组外,其余各组小鼠每只滴鼻35 μl、50 LD
50
A/PR/8/34/H1N1病毒液滴鼻,以制备甲型流感H1N1模型小鼠。于实验第5天至9天每日记录小鼠体质量及计算体质量变化率,并观察一般状态。于第9天取材,计算小鼠肺指数及肺指数抑制率;HE染色法检测肺组织病理变化,并进行肺组织病变评分;RT-qPCR法检测肺组织病毒载量;ELISA法检测上呼吸道灌洗液中分泌型免疫球蛋白A(sIgA)及血清肿瘤坏死因子α(TNF-α)、白细胞介素2(IL-2)、白细胞介素6(IL-6)、干扰素γ(IFN-γ)含量。
结果
2
实验第7、8、9天,模型组小鼠体质量变化率较同时间点正常组显著降低(
P
<0.05或
P
<0.01);实验第8、9天与模型组比较,扎那米韦组和滴鼻高浓度组小鼠体质量变化率增加(
P
<0.05或
P
<0.01)。与正常组比较,模型组小鼠肺指数、肺组织病变评分、肺组织病毒载量明显升高,血清TNF-α、IL-6、IL-2、IFN-γ含量明显升高,上呼吸道灌洗液sIgA水平明显降低(
P
<0.01)。与模型组比较,扎那米韦组和滴鼻高浓度组肺指数、肺组织病毒载量降低,血清IFN-γ、TNF-α、IL-2、IL-6含量降低,sIgA水平升高(
P
<0.05或
P
<0.01);除香囊低浓度组外,其余各药物干预组肺组织病变评分较模型组降低(
P
<0.01)。与扎那米韦组比较,香囊低浓度组和滴鼻低、高浓度组肺指数升高,各香术防感方干预组血清TNF-α、IL-2含量均升高(
P
<0.05或
P
<0.01)。与滴鼻高浓度组比较,香囊高浓度组血清TNF-α和IFN-γ含量升高,滴鼻低浓度组肺组织病毒载量升高(
P
<0.05或
P
<0.01)。扎那米韦组肺指数抑制率为80.84%,香囊高、低浓度组肺指数抑制率分别为41.61%、17.90%,滴鼻高、低浓度组肺指数抑制率分别为35.40%、25.40%。HE染色显示,模型组肺组织出现肺泡间隔增厚,肺泡塌陷,炎性细胞浸润;而各药物干预组小鼠肺组织炎症和损伤程度均有所减轻,且以扎那米韦组、滴鼻高浓度组改善最明显。
结论
2
香术防感方吸嗅和滴鼻两种给药形式均可预防甲型流感H1N1病毒感染,具有抗病毒、抗炎作用,可改善肺组织病理损伤,提高呼吸道黏膜免疫,且滴鼻给药在抑制炎症反应方面可能优于吸嗅给药,尤以滴鼻高浓度效佳。
Objective
2
To compare the effectiveness and mechanism of
Xiangzhu Fanggan Formula
(香术防感方) by sniffing and nasal drops for preventing influenza A H1N1flu.
Methods
2
Fifty-six BALB/c mice were randomly divided into normal group, model group, zanamivir group, high-concentration sachet group, low-concentration sachet group, high-concentration nasal drops group, and low-concentration nasal drops group, with 8 mice in each group. In the low- and high-concentration sachet gr
oups, 15 g and 30 g of
Xiangzhu Fanggan Formula
sachet were used for sniffing for 24 h per day; while in the low- and high-concentration nasal drops groups, nasal drops of
Xiangzhu Fanggan Formula
were given at a concentration of 0.11 and 0.22 g/ml, 20 μl each time, twice a day; in the zanamivir group, zanamivir was given at a concentration of 1.025 mg/ml of 20 μl each time, twice a day; in the normal group and the model group, nasal drops of normal saline were given at 20 μl each time, twice a day. Each group was given prophylactic intervention for 5 days. On day 5, 1 h after the administration of the drug, the mice in all groups except the normal group received 35 μl of 50 LD
50
A/PR/8/34/H1N1 viral solution as nasal drops to prepare influenza A H1N1 model mice. The body mass of the mice was recorded and the rate of change of body mass was calculated daily from day 5 to day 9 of the experiment, and the general status was observed. The mice were sampled on day 9, and the lung index and the inhibition rate of lung index were calculated; HE staining was used to detect pathological changes in lung tissues and to score lung tissue lesions; RT-qPCR was used to detect viral load in lung tissues; and ELISA was used to detect secretory immunoglobulin A (sIgA) and serum tumour necrosis factor α (TNF-α) and interleukin 2 (IL-2), interleukin 6 (IL-6), and interferon γ (IFN-γ) in the lavage fluid of the upper respiratory tract.
Results
2
On days 7, 8 and 9 of the experiment, the rate of change in body mass of mice in the model group significantly lower than that in the normal group at the same time points (
P
<0.05 or
P
<0.01). On days 8 and 9 of the experiment, the rate of change in body mass of mice in the zanamivir group and the high-concentration nasal drops group increased when compared with the model group (
P
<0.05 or
P
<0.01). Compared with the normal group, mice in the model group h
ad significantly higher lung index, lung tissue lesion score, lung tissue viral load, significantly higher serum TNF-α, IL-6, IL-2, IFN-γ levels, and significantly lower sIgA levels in the upper respiratory lavage fluid (
P
<0.01). Compared with the model group, the lung index and lung tissue viral load reduced, serum IFN-γ, TNF-α, IL-2, IL-6 levels reduced, and sIgA levels increased in the zanamivir group and the high-concentration nosal drops group (
P
<0.05 or
P
<0.01); except for low-concentration sachet group, lung tissue lesion scores of the drug intervention groups reduced compared with those of the model group (
P
<0.01). Compared with the zanamivir group, the lung index increased in the low-concentration sachet group and the low- and high-concentration nasal drops groups, and the serum TNF-α and IL-2 levels increased in all
Xiangzhu Fanggan Formula
intervention groups (
P
<0.05 or
P
<0.01). Compared with high-concentration nasal drops group, serum TNF-α and IFN-γ levels elevated in the high-concentration increased group, and lung tissue viral load elevated in the low-concentration nasal drops group (
P
<0.05 or
P
<0.01). The lung index inhibition rate was 80.84% in the zanamivir group, 41.61% and 17.90% in the high- and low-concentration sachet groups, and 35.40% and 25.40% in the high- and low-concentration nasal drops groups, respectively. HE staining showed that the lung tissues of the model group showed thickening of alveolar septa, alveolar collapse, and infiltration of inflammatory cells; whereas, in each drug intervention group, the inflammation of the lung tissues of the mice and the damage reduced, and the most obvious improvement was in the zanamivir group and the high-concentration nasal drops group.
Conclusion
2
Xiangzhu Fanggan Formula
by sniffing and nasal drops could both prevent influenza A H1N1 virus infe
ction, with antiviral and anti-inflammatory effects, also could improve the pathological damage of lung tissue, and improve the immunity of respiratory mucosa. The nasal drops may be better than sachets in inhibiting inflammatory response, especially the high-concentration nasal drops showed more effective.
UYEKI TM , HUI DS , ZAMBON M , et al . Influenza [J]. Lancet , 2022 , 400 ( 10353 ): 693 - 706 .
YAMAYOSHI S , KAWAOKA Y . Current and future influenza vaccines [J]. Nat Med , 2019 , 25 ( 2 ): 212 - 220 .
HAN J , PEREZ J , SCHAFER A , et al . Influenza virus: small molecule therapeutics and mechanisms of antiviral resistance [J]. Curr Med Chem , 2018 , 25 ( 38 ): 5115 - 5127 .
赵静 , 张伟娜 , 李皓月 , 等 . 一种预防流感的中药香囊 : CN112807364B [P]. 2022-03-01 .
董毅智 , 张悦 , 李皓月 , 等 . 从鼻腔黏膜免疫探讨中药外用在流感预防中的应用与前景 [J]. 南京中医药大学学报 , 2022 , 38 ( 11 ): 1009 - 1014 .
李立 , 张弛 , 崔鑫 , 等 . 中药防感香囊对成人流行性感冒预防效果的随机对照预试验 [J]. 中医杂志 , 2019 , 60 ( 20 ): 1747 - 1750 .
LAVELLE EC , WARD RW . Mucosal vaccines-fortifying the frontiers [J]. Nat Rev Immunol , 2022 , 22 ( 4 ): 236 - 250 .
王鑫国 . 中药药理学实验教程 [M]. 2版 . 北京 : 中国中医药出版社 , 2017 : 8 .
杨玉琴 , 徐春华 , 周文江 , 等 . 两种呼吸道感染方式建立小鼠流感病毒感染模型的比较 [J]. 中国实验动物学报 , 2020 , 28 ( 6 ): 773 - 778 .
姚荣妹 , 毛鑫 , 曲天歌 , 等 . 喘可治注射液对甲型H1N1流感病毒FM1株致小鼠肺炎的影响 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 12 ): 43 - 49 .
YE Y , WANG H , LIU J , et al . Polygalasaponin F treats mice with pneumonia induced by influenza virus [J]. Inflammopharmacology , 2020 , 28 ( 1 ): 299 - 310 .
孙巧思 , 胡镜清 , 刘理想 . 论中医学疫病防治特色 [J]. 中国中医基础医学杂志 , 2021 , 27 ( 1 ): 42 - 45,49 .
上海市中医药学会肺系病分会 . 季节性流行性感冒中医预防方案上海专家共识(2022年) [J]. 上海中医药杂志 , 2022 , 56 ( 10 ): 13 - 15,19 .
姚伟 , 赵向东 , 冯全生 . 古代芳香药物在疫病预防中的运用 [J]. 国医论坛 , 2011 , 26 ( 5 ): 47 - 49 .
WU XQ , ZHANG WN , HAO MZ , et al . How Chinese herbal medicine prevents epidemics: from ancient pestilences to COVID-19 pandemic [J]. Am J Chin Med , 2021 , 49 ( 5 ): 1017 - 1044 .
张伟娜 , 李兵 , 赵静 . 古代瘟疫预防方法探析 [J]. 陕西中医 , 2018 , 39 ( 6 ): 787 - 789 .
LI Y , HUO S , YIN Z , et al . The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs [J]. mBio , 2023 , 14 ( 5 ): e0127323 . doi: 10.1128/mbio.01273-23 http://dx.doi.org/10.1128/mbio.01273-23 .
YANG Y , SHAO J , ZHOU Q , et al . Exploration of the mechanisms of Callicarpa nudiflora Hook. et Arn against influenza A virus (H1N1) infection [J]. Phytomedicine , 2024 , 123 : 155240 . doi: 10.1016/j.phymed. 2023. 155240.doi:10.1146/annurev_immunol-032414-112315 http://dx.doi.org/10.1016/j.phymed.2023.155240.doi:10.1146/annurev_immunol-032414-112315 .
IWASAKI A . Exploiting mucosal immunity for antiviral vaccines [J]. Annu Rev Immunol , 2016 , 34 : 575 - 608 .
WU CT , LIDSKY PV , XIAO Y , et al . SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming [J]. Cell , 2023 , 186 ( 1 ): 112 - 130 .
WANG Z , LORENZI JCC , MUECKSCH F , et al . Enhanced SARS-CoV-2 neutralization by dimeric IgA [J]. Sci Transl Med , 2021 , 13 ( 577 ): eabf1555 .
LOBA SM , WATANABE ASA , SALOMAO MLM , et al . Excess mortality is associated with influenza A (H1N1) in patients with severe acute respiratory illness [J]. J Clin Virol , 2019 , 116 : 62 - 68 . doi: 10.1016/j.jcv. 2019. 05.003 http://dx.doi.org/10.1016/j.jcv.2019.05.003 .
ZHANG Y , WANG R , SHI W , et al . Antiviral effect of fufang yinhua jiedu (FFYH) granules against influenza A virus through regulating the inflammatory responses by TLR7/MyD88 signaling pathway [J]. J Ethnopharmacol , 2021 , 275 : 114063 . doi: 10.1016/j.jep.2021.114063 http://dx.doi.org/10.1016/j.jep.2021.114063 .
ZHAO D , CHEN X , WANG L , et al . Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine [J]. Int J Biol Macromol , 2023 , 234 : 123635 . doi: 10.1016/j.ijbiomac.2023.123635 http://dx.doi.org/10.1016/j.ijbiomac.2023.123635 .
LIU ZG , HE J , ZHU TY , et al . Lentinan-functionalized graphene oxide is an effective antigen delivery system that modulates innate immunity and improves adaptive immunity [J]. ACS Appl Mater Interfaces , 2020 , 12 ( 35 ): 39014 - 39023 .
HE J , LIU ZG , JIANG WM , et al . Immune-adjuvant activity of lentinan-modified calcium carbonate microparticles on a H5N1 vaccine [J]. Int J Biol Macromol , 2020 , 163 : 1384 - 1392 . doi: 10.1016/j.ijbiomac.2020.08.005 http://dx.doi.org/10.1016/j.ijbiomac.2020.08.005 .
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010102007558号